3 completed. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
Follow Hyper-IgM Immunodeficiency Syndrome: new trials by email Literature Review of Hyper-IgM Immunodeficiency Syndrome trials Research Report on Hyper-IgM Immunodeficiency Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies CDX-1140, CDX-301, pembrolizumab - Melanoma, Non-small Cell Lung Cancer | Phase 1 | Completed | Celldex Therapeutics | 132 | 2017-12-01 | 2024-03-28 |
| Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous Treatment by clopidogrel - Systemic Lupus Erythematous | Phase 1 / Phase 2 | Completed | University Hospital, Bordeaux | 18 | 2015-08-19 | 2026-05-14 |
| Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells Hematopoietic stem cell transplantation - Sickle Cell Disease, Thalassemia | Phase 1 / Phase 2 | Completed | Children's Hospital Los Angeles | 25 | 2008-08-01 | 2016-06-23 |
Anemia (1) · Anemia, Dyserythropoietic, Congenital (1) · Anemia, Sickle Cell (1) · Bile Duct Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Chediak-Higashi Syndrome (1) · Cholangiocarcinoma (1) · Colorectal Neoplasms (1) · Congenital amegakaryocytic thrombocytopenia (1) · Esophageal Neoplasms (1) · Fallopian Tube Neoplasms (1) · Fucosidosis (1)
Blood Protein Disorders (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Dysgammaglobulinemia (3) · Hematologic Diseases (3) · Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunologic Deficiency Syndromes (3) · Primary Immunodeficiency Diseases (3) · Genetic Diseases, Inborn (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Skin and Connective Tissue Diseases (2) · Adenocarcinoma (1) · Adnexal Diseases (1) · Agranulocytosis (1)
Drug Therapy (1) · Hematopoietic Stem Cell Transplantation (1) · pembrolizumab (1)
Celldex Therapeutics (1) · Children's Hospital Los Angeles (1) · University Hospital, Bordeaux (1)
United States (2) · France (1)
2014 (1)